Last reviewed · How we verify
NCT04276792: JCOIN_TCU
Community Opioid Innovation Network (JCOIN): TCU Clinical Research Center
NA trial testing TCU Opioid-Treatment Linkage Model (O-TLM) in Addiction, Opioid in 18 participants. Currently enrolling.
30 April 2026
Quick facts
| Lead sponsor | Texas Christian University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 18 |
| Start date | 7 October 2021 |
| Primary completion | 30 April 2026 |
| Estimated completion | 30 April 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- TCU Opioid-Treatment Linkage Model (O-TLM)
Conditions studied
- Addiction, Opioid — all drugs for Addiction, Opioid →
Sponsor
Texas Christian University
Who can join
18 and older, any sex, with Addiction, Opioid. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
There are two study periods for the TCU JCOIN project. The primary aims of Study 1 (approved by the TCU IRB) are (1) to gather information from staff on the current treatment referral process within participating communities and (2) to learn about the existing interrelationships between medical and community behavioral health (CBH) providers. TCU IRB granted approval for Phase 1 on 11/07/19, approval number: 1920-60-AM1. Study 2 (under current review by the TCU IRB) includes recruitment across 18 community collaboration sites across 3 states; these communities will participate in the TCU Opioid-Treatment Linkage Model (O-TLM) protocol. The O-TLM is focused on best practices for improving screening, identifying and linking to MOUD providers, reducing stigma, and addressing other important factors that impact justice-involved individuals returning to their communities. Along with their agency records, information collected from justice-involved individuals within the target communities will be examined to assess O-TLM impact on improving public health and public safety outcomes. Furthermore, stakeholder staff across community organizations, including criminal justice and treatment agencies, will be asked to complete surveys on the O-TLM regarding its acceptability and adoption, as well as on best training strategies.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04276792
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Addiction, Opioid
Currently open trials in the same condition.
- NCT06540105 — Leveraging Artificial Intelligence and Multi-Omics Data to Predict Opioid Addiction · recruiting
- NCT05343793 — Stagewise Implementation-To-Target- Medications for Addiction Treatment (SITT-MAT) · NA · active not recruiting
Other Texas Christian University trials
Trials by the same sponsor.
- NCT07271316 — Alii Supplement Study · Phase 2 · recruiting
- NCT07377331 — Exploration of an Online Education Program to Support Caregivers' Knowledge Transfer · Phase 1 · recruiting
- NCT07180446 — Can Gut Bacteria Predict Who Benefits Most From Exercise? A Gut Supplement to Help Exercise Non-Responders · NA · not yet recruiting
- NCT07105826 — Impact of Prebiotic Sodas on Satiety and Metabolic Responses in Healthy Men · NA · recruiting
- NCT07377318 — Project CARE-D - Online Caregiver Education for Dementia · Phase 1 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04276792 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Texas Christian University
- Last refreshed: 17 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04276792.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing